The clinical perspective: How to personalise treatment in MS and how may biomarkers including imaging contribute to this? by Vermersch, P, Berger, T, Gold, R, Lukas, C, Rovira, A, Meesen, B, Chard, D, Comabella, M, Palace, J, Trojano, M

Serial immunoprecipitation assays for interferon--(IFN)-beta antibodies in multiple sclerosis patients. by Lampasona, V, Rio, J, Franciotta, D, Furlan, R, Avolio, C, Fazio, R, Lavolpe, V, Vincent, A, Comi, G, Trojano, M, Montalban, X, Martino, G